BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
G-protein-coupled receptor binding
,
Inflammatory disorder
,
Neuron
,
Laryngoscope
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
1 3- trifluoromethylphenyl)- 2- propanol
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Liver tissues from rats after treatment with different compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
Effective enzymatic resolution of rac-1-(3-trifluoromethylphenyl)propan-2-ol, precursor of fenfluram…
Isolation, identification and excretion profile of the principal urinary metabolite of the recently …
N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymetham…
Measurement of dexfenfluramine metabolism in rat liver microsomes by gas chromatography-mass spectro…
The identification of two new urinary metabolites of fenfluramine in man.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for 1 3- trifluoromethylphenyl)- 2- propanol
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ